{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:38Z","timestamp":1792791518229,"version":"4.5.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.576572","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T12:47:59Z","timestamp":1602247679000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Technical Validation of a Hepatitis C Virus Whole Genome Sequencing Assay for Detection of Genotype and Antiviral Resistance in the Clinical Pathway"],"prefix":"10.3389","volume":"11","author":[{"given":"Carmen F.","family":"Manso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Bibby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieren","family":"Lythgow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hodan","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Piorkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuen T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Azim","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla L. C.","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Mbisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7111.1","article-title":"ve-SEQ: robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens.","volume":"4","author":"Bonsall","year":"2015","journal-title":"F1000Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3201\/eid2204.151812","article-title":"Evaluation of viremia frequencies of a novel human pegivirus by using bioinformatic screening and PCR.","volume":"22","author":"Bonsall","year":"2016","journal-title":"Emerg Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/infdis\/jiy401","article-title":"Identification of a novel hepatitis c virus genotype from punjab, india: expanding classification of hepatitis C virus into 8 genotypes.","volume":"218","author":"Borgia","year":"2018","journal-title":"J. Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jinf.2019.10.007","article-title":"Consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection: Public Health England HCV Resistance Group.","volume":"79","author":"Bradshaw","year":"2019","journal-title":"J. Infect."},{"key":"B5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3892\/ijmm.2012.1209","article-title":"Comparison of three different HCV genotyping methods: core, NS5B sequence analysis and line probe assay.","volume":"31","author":"Cai","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jviromet.2013.11.002","article-title":"Fast, reliable and low cost user-developed protocol for detection, quantification and genotyping of hepatitis C virus.","volume":"196","author":"Davalieva","year":"2014","journal-title":"J. Virol. Methods"},{"key":"B7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL Recommendations on Treatment of Hepatitis C 2018.","volume":"69","year":"2018","journal-title":"J. Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1086\/319231","article-title":"Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy.","volume":"32","author":"Hanna","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"B9","author":"Harris","year":"2007","journal-title":"Improved Pairwise Alignment of Genomic DNA."},{"key":"B10","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/00126334-200103011-00006","article-title":"International perspectives on antiretroviral resistance. Clinical utility of resistance testing: retrospective and prospective data supporting use and current recommendations.","volume":"26","author":"Haubrich","year":"2001","journal-title":"J. Acquir Immune Defic Syndr."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l1994","article-title":"NHS England finalises procurement to eliminate hepatitis C.","volume":"365","author":"Hawkes","year":"2019","journal-title":"BMJ"},{"key":"B12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/hep.27361","article-title":"Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir\/ribavirin.","volume":"61","author":"Hedskog","year":"2015","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/bioinformatics\/btr708","article-title":"ART: a next-generation sequencing read simulator.","volume":"28","author":"Huang","year":"2012","journal-title":"Bioinformatics"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155869","article-title":"Geno2pheno[HCV] - a web-based interpretation system to support hepatitis C treatment decisions in the era of direct-acting antiviral agents.","volume":"11","author":"Kalaghatgi","year":"2016","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1001\/jama.2014.7085","article-title":"Treatment of hepatitis C: a systematic review.","volume":"312","author":"Kohli","year":"2014","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/bioinformatics\/bth485","article-title":"The Los Alamos hepatitis C sequence database.","volume":"21","author":"Kuiken","year":"2005","journal-title":"Bioinformatics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/srep33318","article-title":"Contamination-controlled high-throughput whole genome sequencing for influenza A viruses using the MiSeq sequencer.","volume":"6","author":"Lee","year":"2016","journal-title":"Sci. Rep."},{"key":"B18","author":"Li","year":"2013","journal-title":"Aligning Sequence Reads, Clone Sequences and Assembly Contigs With BWA-MEM."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools.","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/s0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"B21","article-title":"Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UK.","volume":"20","author":"Mbisa","year":"2020","journal-title":"J. Antimicrob Chemother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/jvh.12849","article-title":"Prevalence of mixed genotype hepatitis C virus infections in the UK as determined by genotype-specific PCR and deep sequencing.","volume":"25","author":"Mcnaughton","year":"2018","journal-title":"J. Viral Hepat."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26544","article-title":"Mixed genotype hepatitis C infections and implications for treatment.","volume":"59","author":"Mcnaughton","year":"2014","journal-title":"Hepatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1099\/0022-1317-76-10-2493","article-title":"Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group.","author":"Mellor","year":"1995","journal-title":"J. Gen. Virol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094249","article-title":"Analysis, optimization and verification of Illumina-generated 16S rRNA gene amplicon surveys.","volume":"9","author":"Nelson","year":"2014","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-11-56","article-title":"Reliable reconstruction of HIV-1 whole genome haplotypes reveals clonal interference and genetic hitchhiking among immune escape variants.","volume":"11","author":"Pandit","year":"2014","journal-title":"Retrovirology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection.","volume":"67","author":"Panel","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/v12070694","article-title":"Multi-laboratory comparison of next-generation to sanger-based sequencing for HIV-1 drug resistance genotyping.","volume":"12","author":"Parkin","year":"2020","journal-title":"Viruses"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143081","article-title":"Assessment of the utility of whole genome sequencing of measles virus in the characterisation of outbreaks.","volume":"10","author":"Penedos","year":"2015","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3851\/IMP3318","article-title":"Performance assessment of a fully automated deep sequencing platform for HCV resistance testing.","volume":"24","author":"Rodriguez","year":"2019","journal-title":"Antivir Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22614-0","article-title":"A novel standardized deep sequencing-based assay for hepatitis C virus genotype determination.","volume":"8","author":"Rodriguez","year":"2018","journal-title":"Sci. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1309\/ajcpr88wdjjldmbn","article-title":"Occult specimen contamination in routine clinical next-generation sequencing testing.","volume":"144","author":"Sehn","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv694","article-title":"A new method to prevent carry-over contaminations in two-step PCR NGS library preparations.","volume":"43","author":"Seitz","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/v11040323","article-title":"Interpreting viral deep sequencing data with GLUE.","volume":"11","author":"Singer","year":"2019","journal-title":"Viruses"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2459-9","article-title":"GLUE: a flexible software system for virus sequence data.","volume":"19","author":"Singer","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource.","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"B37","author":"Smith","year":"2019","journal-title":"A Web Resource to Manage the Classification and Genotype and Subtype Assignments of Hepatitis C Virus [Online]. International Committee on Taxonomy of Viruses."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz329","article-title":"Epidemiological and clinical characteristics of human hepegivirus 1 infection in patients with hepatitis C.","volume":"6","author":"Sridhar","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jhep.2017.05.027","article-title":"Origin, prevalence and response to therapy of hepatitis C virus genotype 2k\/1b chimeras.","volume":"67","author":"Susser","year":"2017","journal-title":"J. Hepatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1128\/jcm.00330-16","article-title":"Comparison of next-generation sequencing technologies for comprehensive assessment of full-length hepatitis C viral genomes.","volume":"54","author":"Thomson","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/cid\/cix748","article-title":"A novel human pegivirus, HPgV-2 (HHpgV-1), is tightly associated with hepatitis C virus (HCV) infection and HCV\/human immunodeficiency virus type 1 coinfection.","volume":"66","author":"Wang","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1586\/14737159.5.4.507","article-title":"Molecular methods of hepatitis C genotyping.","volume":"5","author":"Weck","year":"2005","journal-title":"Expert Rev. Mol. Diagn"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-13-475","article-title":"De novo assembly of highly diverse viral populations.","volume":"13","author":"Yang","year":"2012","journal-title":"BMC Genomics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.jhep.2017.01.007","article-title":"NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: prevalence and effect on treatment outcome.","volume":"66","author":"Zeuzem","year":"2017","journal-title":"J. Hepatol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.576572\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T12:48:07Z","timestamp":1602247687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.576572\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":44,"alternative-id":["10.3389\/fmicb.2020.576572"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.576572","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"article-number":"576572"}}